GRFS - יחס חוב להיוון בספרים Grifols SA

Serving as the primary valuation tool, this chart on GURU.Markets illustrates the price action of Grifols, S.A. (GRFS), where management has transitioned to hired professionals to reduce debt, and the indicator stands at 1.54. The business is expanding its influence in the biologics sector through the acquisition of plasma centers and scientific partnerships. Meanwhile, Grifols, S.A. (GRFS) maintains internal control over plasma fractionation while outsourcing logistics.

This metric decouples the fundamental stability of Grifols, S.A. (GRFS) from market volatility by measuring the share of total liabilities within the equity structure to assess financial leverage. By analyzing this leverage chart—debt to book capitalization—investors can monitor management reorganization risks, while a successful recovery in plasma collection margins confirms the company's ability to maintain its debt load within safe limits.